In particular, AR expression has been most commonly associated with estrogen receptor-positive (ER-positive) breast cancers, where it is believed to exert a tumor-suppressive role by competing with estrogen receptors for binding to DNA and regulating the transcription of genes involved in cell proliferation [69,122]. Here, ESR1 is linked to breast carcinoma.